BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 19439956)

  • 1. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
    Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
    Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of Barrett's esophagus: can it prevent cancer?
    Sampliner RE
    Surg Oncol Clin N Am; 2009 Jul; 18(3):503-8. PubMed ID: 19500739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
    Morgan G
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's-related esophageal adenocarcinoma: is chemoprevention a potential option?
    Fennerty MB; Triadafilopoulos G
    Am J Gastroenterol; 2001 Aug; 96(8):2302-5. PubMed ID: 11513166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention in Barrett's esophagus: A pill a day?
    Jankowski JA; Hooper PA
    Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):155-70. PubMed ID: 21112505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Barrett's adenocarcinoma].
    Mafune K
    Nihon Rinsho; 2005 Aug; 63(8):1463-9. PubMed ID: 16101241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GERD and Barrett's esophagus: diagnostic and management strategies in the geriatric population.
    Morganstern B; Anandasabapathy S
    Geriatrics; 2009 Jul; 64(7):9-12. PubMed ID: 19586085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and recognition of early esophageal neoplasia.
    Herszényi L; Pregun I; Tulassay Z
    Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention in Barrett's Esophagus: Current Status.
    Zeb MH; Baruah A; Kossak SK; Buttar NS
    Gastroenterol Clin North Am; 2015 Jun; 44(2):391-413. PubMed ID: 26021201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoluminal therapy for esophageal disease: an introduction.
    Wolfsen HC
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):1-10, v. PubMed ID: 19951790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
    Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
    Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cancer risk in Barrett's esophagus.
    Tan A; Macrae F
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?
    Fennerty MB
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S30-7. PubMed ID: 12478242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
    Wang F; Lv ZS; Fu YK
    Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of obesity in Barrett's esophagus and cancer.
    Murray L; Romero Y
    Surg Oncol Clin N Am; 2009 Jul; 18(3):439-52. PubMed ID: 19500735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.